top of page
iPharmaCenter
For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com
Search
ipharmaservices
Jun 13, 2019
ipharmaservices
Jun 13, 2019
ipharmaservices
Jun 12, 2019
ipharmaservices
Jun 12, 2019
ipharmaservices
Jun 11, 2019
ipharmaservices
Jun 10, 2019
ipharmaservices
Jun 9, 2019
ipharmaservices
Jun 6, 2019
ipharmaservices
Jun 6, 2019
ipharmaservices
Jun 4, 2019
ipharmaservices
Jun 4, 2019
ipharmaservices
Jun 3, 2019
ipharmaservices
Jun 1, 2019
ipharmaservices
Jun 1, 2019
ipharmaservices
May 31, 2019
Celgene’s Revlimid in combination with rituximab is indicated for the treatment of previously treate
ipharmaservices
May 29, 2019
ipharmaservices
May 26, 2019
ipharmaservices
May 24, 2019
AbbVie’s cancer product Depatux-M (Depatuxizumab Mafodotin) did not reach the primary endpoint in th
ipharmaservices
May 17, 2019
FDA approved Pfizer’s Fragmin for the treatment potentially life-threatening blood clots for pediatr
ipharmaservices
May 16, 2019
bottom of page